INTEGER HOLDINGS CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
INTEGER HOLDINGS CORPORATION (ITGR) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2026-02-23
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2024-12-31 was $0.00.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2024-09-27 was $0.00.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2024-06-28 was $0.00, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2025 was $0.00.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2023 was $11.18M, a 1049.90% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2022 was $972.00K, a 40.04% decline from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-23 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 |
| 2024-09-27 | $0.00 10-Q · filed 2024-10-24 | $0.00 derived: sum of 2 quarters · filed 2024-10-24 | $0.00 10-Q · filed 2024-10-24 | |
| 2024-06-28 | $0.00 10-Q · filed 2024-07-25 | $0.00 10-Q · filed 2024-07-25 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $11.18M derived: sum of 3 quarters · filed 2026-02-23 | $11.18M 10-K · filed 2026-02-23 |
| 2023-09-29 | $0.00 10-Q · filed 2024-10-24 | $11.18M derived: sum of 2 quarters · filed 2024-10-24 | $11.18M 10-Q · filed 2024-10-24 | $11.66M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $11.18M 10-Q · filed 2024-07-25 | $11.18M 10-Q · filed 2024-07-25 | $11.66M derived: sum of 3 quarters · filed 2025-02-20 | $11.66M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $0.00 10-Q · filed 2023-04-27 | $479.00K derived: sum of 2 quarters · filed 2025-02-20 | $479.00K derived: sum of 3 quarters · filed 2025-02-20 | $479.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $479.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $479.00K derived: sum of 2 quarters · filed 2025-02-20 | $479.00K derived: sum of 3 quarters · filed 2025-02-20 | $972.00K 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-26 | $0.00 derived: sum of 2 quarters · filed 2023-10-26 | $493.00K 10-Q · filed 2023-10-26 | $493.00K derived: sum of 4 quarters · filed 2023-10-26 |
| 2022-07-01 | $0.00 10-Q · filed 2023-07-27 | $493.00K 10-Q · filed 2023-07-27 | $493.00K derived: sum of 3 quarters · filed 2023-07-27 | $493.00K derived: sum of 4 quarters · filed 2023-07-27 |
| 2022-04-01 | $493.00K 10-Q · filed 2023-04-27 | $493.00K derived: sum of 2 quarters · filed 2023-04-27 | $493.00K derived: sum of 3 quarters · filed 2023-04-27 | $493.00K derived: sum of 4 quarters · filed 2023-04-27 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $0.00 derived: sum of 3 quarters · filed 2023-02-21 | $1.62M 10-K · filed 2023-02-21 |
| 2021-10-01 | $0.00 10-Q · filed 2022-10-27 | $0.00 derived: sum of 2 quarters · filed 2022-10-27 | $1.62M 10-Q · filed 2022-10-27 | $1.62M derived: sum of 4 quarters · filed 2022-10-27 |
| 2021-07-02 | $0.00 10-Q · filed 2022-07-28 | $1.62M 10-Q · filed 2022-07-28 | $1.62M derived: sum of 3 quarters · filed 2022-07-28 | $2.12M derived: sum of 4 quarters · filed 2022-07-28 |
| 2021-04-02 | $1.62M 10-Q · filed 2022-04-28 | $1.62M derived: sum of 2 quarters · filed 2022-04-28 | $2.12M derived: sum of 3 quarters · filed 2022-04-28 | $2.62M derived: sum of 4 quarters · filed 2022-04-28 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $500.00K derived: sum of 2 quarters · filed 2022-02-22 | $1.00M derived: sum of 3 quarters · filed 2022-02-22 | $1.00M 10-K · filed 2022-02-22 |
| 2020-10-02 | $500.00K 10-Q · filed 2021-10-28 | $500.00K 10-Q · filed 2020-10-29 | $1.00M 10-Q · filed 2021-10-28 | |
| 2020-07-03 | $500.00K 10-Q · filed 2020-07-30 | $500.00K 10-Q · filed 2021-07-29 | ||
| 2020-04-03 | $0.00 10-Q · filed 2021-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |